Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross-sectional, Interventional, Single-arm Clinical Study for Validating the Equivalence of Bloomlife MFM-Pro to Clinical Standard-of-care for Fetal Heart Rate and Maternal Heart Rate When Performing Antepartum Fetal Monitoring

NCT04915131 is registered in ClinicalTrials.gov with Bloom Technologies as lead sponsor.

NCT NCT04915131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04915131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross-sectional, Interventional, Single-arm Clinical Study for Validating the Equivalence of Bloomlife MFM-Pro to Clinical Standard-of-care for Fetal Heart Rate and Maternal Heart Rate When Performing Antepartum Fetal Monitoring
Lead sponsor
Bloom Technologies
Phase
Not applicable
Overall status
Completed
Start date
April 6, 2021
Completion date
May 5, 2022
Enrollment
121 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fetal monitoring